Bio-View Ltd (TLV:BIOV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
14.10
-0.10 (-0.71%)
Apr 3, 2026, 1:44 PM IDT

Bio-View Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
19.9325.6634.7729.1530.51
Revenue Growth (YoY)
-22.31%-26.21%19.29%-4.48%17.54%
Cost of Revenue
10.4110.0913.3912.4812.93
Gross Profit
9.5215.5621.3816.6717.59
Selling, General & Admin
12.6211.8812.8311.729.7
Research & Development
4.76.668.414.855.33
Other Operating Expenses
0.020-0.49--
Operating Expenses
17.3418.5420.7516.5715.03
Operating Income
-7.82-2.970.630.12.56
Interest Expense
-1.32-0.22-0.31-0.24-0.23
Interest & Investment Income
-0.390.440.030.02
Currency Exchange Gain (Loss)
-0.10.141.05-0.59
Other Non Operating Income (Expenses)
--0.16-0.1-0.07-0.06
EBT Excluding Unusual Items
-9.15-2.860.80.881.7
Gain (Loss) on Sale of Assets
-----0.01
Other Unusual Items
----0.99
Pretax Income
-9.15-2.860.80.882.68
Income Tax Expense
6.190.290.410.290.5
Net Income
-15.33-3.150.380.592.18
Net Income to Common
-15.33-3.150.380.592.18
Net Income Growth
---34.75%-73.12%147.06%
Shares Outstanding (Basic)
136133135139140
Shares Outstanding (Diluted)
136133135139140
Shares Change (YoY)
2.17%-1.92%-2.64%-0.49%-0.60%
EPS (Basic)
-0.11-0.020.000.000.02
EPS (Diluted)
-0.11-0.020.000.000.02
EPS Growth
---32.99%-72.99%160.43%
Free Cash Flow
-3.11-3.14-0.120.512.59
Free Cash Flow Per Share
-0.02-0.02-0.000.000.02
Gross Margin
47.76%60.66%61.48%57.20%57.63%
Operating Margin
-39.25%-11.59%1.81%0.35%8.38%
Profit Margin
-76.93%-12.27%1.10%2.01%7.16%
Free Cash Flow Margin
-15.60%-12.24%-0.35%1.75%8.48%
EBITDA
-5.98-2.680.951.64.03
EBITDA Margin
-30.01%-10.43%2.73%5.48%13.22%
D&A For EBITDA
1.840.30.321.51.48
EBIT
-7.82-2.970.630.12.56
EBIT Margin
-39.25%-11.59%1.81%0.35%8.38%
Effective Tax Rate
--51.94%32.91%18.60%
Advertising Expenses
-0.220.120.170.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.